Osteoporotic fractures cost China's healthcare system close to 10 billion USD annually

November 15, 2014

Taipei, November 15, 2014 - An epidemiological study presented today at the 5th Asia-Pacific Osteoporosis Meeting is one of the first to project the immense and growing economic cost of osteoporotic fractures in China.

The study, by investigators from the University of Tasmania, Anhui Medical University and Nanjing Medical University, used decision analytic modelling to estimate the burden of osteoporotic fractures. The researchers estimated that in 2010 more than 2.3 million osteoporosis-related hip, clinical vertebral and wrist fractures occurred in the population aged 50 years and over, costing the Chinese healthcare system US$9.61 billion. Women sustained approximately three times more fractures than males, accounting for 73 % of the total costs.

Even more alarming is the fact that the high costs of osteoporosis-related fractures will greatly increase in the future, representing an enormous socio-economic burden in China.

According to a recent International Osteoporosis Foundation Asia-Pacific Audit Report, almost half (49%) of the total population in China will be aged 50 years and over by 2050, and 263 million seniors will be aged 70 years and over - the population group most at risk of costly and disabling hip fractures. Reflecting this expected increase in the ageing population, the researchers project that the annual incidence and costs of osteoporotic fractures will double by 2035. By 2050 the number of fractures is expected to increase to 5.93 million resulting in costs of approximately US$25.58 billion.

As a result there is an urgent need for healthcare resource planning as well as cost-effective screening and intervention policies to minimize the future socio-economic impact of fractures on the Chinese healthcare system.
-end-
The cost-effectiveness model used in the research study 'Projection of incidence and economic burden of osteoporosis-related fractures in China: 2010-2050' was presented at the 5th Asia-Pacific Osteoporosis Meeting, with the complete paper to be published soon in an upcoming issue of the scientific journal 'Osteoporosis International'.

IOF Regionals 5th Asia-Pacific Osteoporosis Meeting

The 5th Asia-Pacific Osteoporosis Meeting is being held in Taipei from November 14-16, 2014. Organized in cooperation with national and regional societies, the IOF Regionals have been a key educational and research forum in the Asia-Pacific region since 2010. Past Meetings have been held in Hong Kong CN, Kuala Lumpur, Australia, and Singapore. The 6th IOF Regionals Asia-Pacific Meeting is planned in Singapore in November 2016.

Information about these and other IOF congresses and training courses is available at http://www.iofbonehealth.org/upcoming-events

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 200 patient, medical and research societies, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / https://twitter.com/iofbonehealth

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.